JP2945054B2 - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JP2945054B2
JP2945054B2 JP2052242A JP5224290A JP2945054B2 JP 2945054 B2 JP2945054 B2 JP 2945054B2 JP 2052242 A JP2052242 A JP 2052242A JP 5224290 A JP5224290 A JP 5224290A JP 2945054 B2 JP2945054 B2 JP 2945054B2
Authority
JP
Japan
Prior art keywords
skin
protein
sepia
external preparation
squid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2052242A
Other languages
Japanese (ja)
Other versions
JPH03255016A (en
Inventor
勝 真子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP2052242A priority Critical patent/JP2945054B2/en
Publication of JPH03255016A publication Critical patent/JPH03255016A/en
Application granted granted Critical
Publication of JP2945054B2 publication Critical patent/JP2945054B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、イカスミの蛋白質や糖蛋白質を加水分解し
た液を有効成分とした色白・細胞賦活機能を有する化粧
料・医薬部外品等の皮膚外用剤に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to cosmetics and quasi-drugs having a fair-skin / cell activating function using a solution obtained by hydrolyzing cuttlefish proteins and glycoproteins as an active ingredient. It relates to a skin external preparation.

〔従来の技術〕[Conventional technology]

従来、動植物エキスを配合した化粧料は多く知られて
いる。
Conventionally, many cosmetics containing animal and plant extracts are known.

例えば、動物エキスとしては、人または哺乳動物の胎
盤エキス,動物・鳥類の肝臓・脾臓エキスが化粧料に使
用されており、植物エキスとしては、各種の生薬類,漢
方薬,ハーブ類、海藻のエキスが用いられ、色白,保
湿,細胞賦活等の機能を示すものとして多用されてき
た。
For example, human or mammalian placenta extracts and animal / bird liver / spleen extracts are used in cosmetics as animal extracts, and various crude drugs, herbal medicines, herbs, and seaweed extracts are used as plant extracts. Has been widely used to show functions such as fairness, moisturizing, and cell activation.

また、単味成分で色色効果を示す物質として、アスコ
ルビン酸,コロイド硫黄,コウジ酸,ハイドロキノン、
及び不飽和脂肪酸等が知られており、これら色白物質を
有効成分とするクリーム,ローション,乳液,パック
剤,軟膏,パップ剤等の外用剤として使用に供せられて
きた。
In addition, as a simple component that exhibits a color effect, ascorbic acid, colloidal sulfur, kojic acid, hydroquinone,
And unsaturated fatty acids are known, and have been used as external preparations such as creams, lotions, emulsions, packs, ointments, cataplasms and the like containing these fair-skin substances as active ingredients.

一方、イカまたはタコのスミから得られた分子量25,0
00〜160,000の高分子物質が抗炎症剤として使用される
ことが、特開昭57−4998号公報及び特開昭64−63523号
公報に、天然メラニン顆粒を含有した皮膚化粧料が特開
昭49−71149号公報に、さらに、黒色顔料としてセピア
メラニンを配合したメイクアップ化粧料が特開昭55−53
211号公報にそれぞれ開示されているが、これらは、い
ずれもイカスミ中に含まれるメラニン顆粒を抗炎症剤や
化粧料として利用するもので、本発明が目的とする色白
効果を期待するものとは異なるし、しかも、成分中から
メラニン顆粒を除いたイカスミの蛋白質または糖蛋白質
を加水分解によって低分子化したものを有効成分とする
という技術思想は全く見当たらない。
On the other hand, molecular weight 25,0 obtained from squid or octopus sumi
Japanese Patent Application Laid-Open Nos. 57-4998 and 64-63523 discloses that skin cosmetics containing natural melanin granules are disclosed in JP-A-57-4998 and JP-A-64-63523. Japanese Unexamined Patent Publication No. 49-71149 further discloses a makeup cosmetic containing sepia melanin as a black pigment.
No. 211, each of which utilizes the melanin granules contained in squid as an anti-inflammatory agent or cosmetic, and those which are expected to have the fair-skin effect aimed at by the present invention. It is different, and there is no technical idea that a protein or glycoprotein of cuttlefish obtained by removing the melanin granules from the components into low molecular weight by hydrolysis is used as an active ingredient.

〔発明が解決しようとする課題〕[Problems to be solved by the invention]

本出願人は、早くからコウジ酸を色白成分とする色白
外用剤を開発し、例えば、特公昭56−18569号公報、特
開昭53−3538号公報等に開示している。
The present applicant has developed a complexion for external use containing kojic acid as a complexion component early on and disclosed in, for example, JP-B-56-18569 and JP-A-53-3538.

本発明者は、このような色白や保湿、細胞賦活機能を
示す外用剤について研究を重ねてきたが、その研究のな
かで、今まで廃棄処分されてきたイカのスミを特殊の処
理を行うことにより得られた液が、優れたメラニン生成
抑制作用と線維芽細胞の賦活増殖性を示すという知見を
得、この知見をもとに本発明を完成させるに至った。
The present inventor has been studying such external preparations that show such fairness, moisturizing, and cell activating functions.In this research, special treatment was carried out on squid stains that had been discarded until now. Have been found to exhibit excellent melanin production inhibitory activity and fibroblast activation and proliferation, and have completed the present invention based on this finding.

〔課題を解決するための手段〕[Means for solving the problem]

本発明によれば、イカスミの蛋白質及び糖蛋白質を加
水分解した液を有効成分とする皮膚外用剤が提供され
る。
According to the present invention, there is provided an external preparation for skin containing, as an active ingredient, a solution obtained by hydrolyzing cuttlefish proteins and glycoproteins.

原料は、イカ・タコ類のスミが用いられるが、イカの
スミが大量に入手し易い点で好ましく用いられる。イカ
の種類は特に限定されるものではないが、一例としてモ
ンゴウイカのスミについて述べる。
As a raw material, squid / octopus sumi is used, and squid sumi is preferably used because it is easily available in large quantities. Although the type of squid is not particularly limited, a squid of Mongouika will be described as an example.

新鮮なイカスミを集めて凍結保存し必要時解凍して用
いる。解凍スミは水を加えて希釈し、濾過するか、遠心
分離を行って、黒色色素粒であるメラニンその他の不溶
性物質を除き、透明粘稠な液を得、これをさらにpH3〜
4の間で等電点沈澱を行い、蛋白質及び糖蛋白質の沈澱
物を集めて、中性の水に再溶解させる。この溶液はその
ままでは高分子量のものが多いため不安定であるので、
必要に応じて濾過を行った後、これを蛋白分解を行う。
分解は、酸やアルカリの加熱加水分解でも良いが、おだ
やかな蛋白分解酵素で行うのが好ましい。
Fresh squid is collected, frozen and thawed when necessary. Thawed sumi is diluted by adding water, filtered or centrifuged to remove melanin and other insoluble substances, which are black pigment particles, to obtain a transparent viscous liquid, which is furthermore pH 3 ~.
An isoelectric precipitation is performed between 4 and the protein and glycoprotein precipitates are collected and redissolved in neutral water. Since this solution is unstable as it is because it has many high molecular weights,
After filtration as required, this is subjected to proteolysis.
The decomposition may be carried out by heat hydrolysis of an acid or alkali, but is preferably carried out with a mild protease.

酵素は、アクチナーゼ(プロナーゼ),パパイン,ペ
プシン,トリプシン等どれでも良いが、それぞれの最適
pH、温度条件で行えば良い。
The enzyme may be any of actinase (pronase), papain, pepsin, trypsin, etc.
It may be performed under pH and temperature conditions.

その条件としては、例えば、アクチナーゼの場合は、
pH8〜9,温度45〜55℃で5時間、パパインではpH6.5〜7.
5,温度40〜50℃で5時間、ペプシンではpH2.0〜3.0,温
度35〜45℃で5時間、トリプシンではpH7.0〜8.0,温度3
5〜45℃で5時間等の条件を例示できるが、他の蛋白分
解酵素の場合でも適宜分解できることはいうまでもな
い。
As the conditions, for example, in the case of actinase,
pH8-9, temperature 45-55 ° C for 5 hours, papain pH6.5-7.
5, 5 hours at 40 to 50 ° C, pH 2.0 to 3.0 for pepsin, 5 hours at 35 to 45 ° C, pH 7.0 to 8.0 for trypsin, temperature 3
Conditions such as 5 hours at 5 to 45 ° C can be exemplified, but it goes without saying that other proteases can be appropriately degraded.

分解が終了したらpHを中性にもどし、90〜100℃で10
分間加熱して蛋白分解酵素を失活させ、冷却後濾過し、
メンブランフィルターで除菌して製品(以後、これをセ
ピアプロテインという)とする。
After the decomposition is completed, the pH is returned to neutral, and the pH is 10
Heat for a minute to inactivate the proteolytic enzymes, filter after cooling,
The product is sterilized by a membrane filter to obtain a product (hereinafter referred to as sepia protein).

製造例 具体的な製造例を次にあげる。Production Example A specific production example is shown below.

凍結モンゴウイカのスミ500gに精製水1500ml(イカス
ミに対して3倍量)加えて解凍し、これを8000〜10,000
Gで遠心分離して、不溶物を除く。この上澄液に10%乳
酸を添加してpHを3.5に調整し、5℃で一晩放置して生
じた沈澱物を集める。この沈澱物に500mlを水を加え、
水酸化ナトリウムの10%水溶液を添加してpHを8.0に調
整する。この液に蛋白質分解酵素(アクチナーゼE,1×1
06PU/g,科研製薬製)を加えて50℃で5時間攪拌分解す
る。分解後、95℃10時間加熱して酵素を失活させ、室温
まで冷却後、pHを7.0に調整し、0.45μmのメンブラン
フィルターで除菌濾過を行って製品とする。収量は450m
l前後である。
Add 500 ml of purified water (3 times the amount of squid) to 500 g of frozen mongo squid and thaw.
Centrifuge at G to remove insolubles. The pH of the supernatant is adjusted to 3.5 by adding 10% lactic acid, and the resulting precipitate is left overnight at 5 ° C. to collect a precipitate. 500 ml of water was added to the precipitate,
The pH is adjusted to 8.0 by adding a 10% aqueous solution of sodium hydroxide. Add the proteolytic enzyme (actinase E, 1 × 1
( 6 PU / g, manufactured by Kaken Pharmaceutical Co., Ltd.) and stirred at 50 ° C. for 5 hours for decomposition. After decomposition, the enzyme is inactivated by heating at 95 ° C. for 10 hours, cooled to room temperature, adjusted to pH 7.0, and sterilized and filtered through a 0.45 μm membrane filter to obtain a product. Yield 450m
l around.

このようにして得られたセピアプロテインは、下記の
物性を有する。
The sepia protein thus obtained has the following physical properties.

1.比重 1.002 2.pH 7.27 3.総窒素 0.02% 4.糖質 0.08% 5.蒸発残留物 0.26% 6.遊離アミノ酸組成 ( )内は遊離アミノ酸中のw/w%を示す。ロイシン
(15.4%),フェニルアラニン(9.7%),チロシン
(9.1%),イソロイシン(8.7%),アルギニン(6.9
%),バリン(6.7%),アラニン(6.2%),セリン
(5.2%),メチオニン(4.9%),トレオニン(4.
7),アスパラギン(4.7%),リジン(4.3%),ヒス
チジン(3.7%),グルタミン(3.1%),アスパラギン
酸(2.0%),グルタミン酸(1.7%),グリシン(1.4
%),シトルリン(0.7%),プロリン(0.4%),シス
チン(0.3%),タウリン(0.2%) 本発明における皮膚外用剤としては、軟膏剤,乳剤,
ローション剤,クリーム,乳液,化粧水,パック剤,パ
ップ剤等の一般に皮膚に塗布する製剤を挙げることがで
き、セピアプロテインの配合割合は、これら皮膚外用剤
の基剤に対して、0.01〜50重量%、好ましくは、0.5〜2
0.0重量%である。
1. Specific gravity 1.002 2. pH 7.27 3. Total nitrogen 0.02% 4. Carbohydrate 0.08% 5. Evaporation residue 0.26% 6. Free amino acid composition Figures in parentheses indicate w / w% of free amino acids. Leucine (15.4%), phenylalanine (9.7%), tyrosine (9.1%), isoleucine (8.7%), arginine (6.9%)
%), Valine (6.7%), alanine (6.2%), serine (5.2%), methionine (4.9%), threonine (4.
7), asparagine (4.7%), lysine (4.3%), histidine (3.7%), glutamine (3.1%), aspartic acid (2.0%), glutamic acid (1.7%), glycine (1.4%)
%), Citrulline (0.7%), proline (0.4%), cystine (0.3%), taurine (0.2%) As the external preparation for skin in the present invention, ointments, emulsions,
Lotions, creams, emulsions, lotions, packs, cataplasms and other preparations generally applied to the skin can be mentioned. The mixing ratio of sepia protein is 0.01 to 50 with respect to the base of these external preparations for skin. % By weight, preferably 0.5-2
0.0% by weight.

本発明において使用するセピアプロテインは、前記外
用剤に使用される一般常用基剤に、他の助剤(たとえ
ば、酸化防止剤,防腐剤,UV吸収剤,キレート防止剤
等)とともに適宜配合使用されるが、皮膚外用剤が乳化
剤型の場合にはセピアプロテインは水層部に配合する。
The sepia protein used in the present invention is appropriately blended and used with a general base used for the above-mentioned external preparation together with other auxiliaries (for example, antioxidants, preservatives, UV absorbers, chelating agents, etc.). However, when the external preparation for skin is an emulsifier type, sepia protein is added to the aqueous layer.

皮膚外用剤の調製例 ・軟膏剤 精製水に、セピアプロテイン及びグリセリンやソルビ
ット等の保湿剤からなる親水性成分を加えて水相部とす
る。
Preparation example of skin external preparation ・ Ointment Sepia protein and a hydrophilic component consisting of a humectant such as glycerin or sorbite are added to purified water to form an aqueous phase.

一方、ミツロウ,パラフィン,マイクロクリスタンワ
ックス,セレシン,高級脂肪酸,硬化油等の固形油分、
ワセリン,ラノリン,グリセリド等の半固形油分、それ
にスクワラン,流動パラフィン,各種エステル油等の液
状油分に、防腐剤,界面活性剤等の油性成分を配合して
油相部とする。
On the other hand, solid oil components such as beeswax, paraffin, microcrystalline wax, ceresin, higher fatty acids, and hardened oils,
Oil components such as preservatives and surfactants are blended with semi-solid oils such as petrolatum, lanolin and glyceride, and liquid oils such as squalane, liquid paraffin and various ester oils to form an oil phase.

次に水相部を加温し、約80〜85℃程度に高められたと
ころで、同程度の温度に加温された油相部を徐々に添加
し、乳化して軟膏とする。
Next, the aqueous phase is heated, and when the temperature is raised to about 80 to 85 ° C., the oil phase heated to the same temperature is gradually added and emulsified to form an ointment.

・ローション剤 精製水に、セピアプロテイン、及びグリセリンやプロ
ピレングリコール等の保湿剤や皮膚栄養剤等をアルコー
ルに溶解したものを室温下に混合してローションとす
る。
・ Lotion A lotion is prepared by dissolving sepia protein, a humectant such as glycerin or propylene glycol, or a skin nutrient in alcohol, in purified water at room temperature.

・クリーム 精製水に、セピアプロテイン、及びグリセリンやソル
ビット等の親水性成分を加えて水相部を調製する。これ
とは別に、ミツロウ,パラフィン,マイクロクリスタン
ワックス,セレシン,高級脂肪酸,硬化油等の固形油
分、スクワラン,流動パラフィン,各種エステル油等の
流状油分、並びに防腐剤や界面活性剤等の油性成分を混
合して油相部を調製する。
・ Cream Sepia protein and hydrophilic components such as glycerin and sorbitol are added to purified water to prepare an aqueous phase. Separately, solid oils such as beeswax, paraffin, microcrystalline wax, ceresin, higher fatty acids, and hardened oils, liquid oils such as squalane, liquid paraffin, various ester oils, and oily components such as preservatives and surfactants To prepare an oil phase.

次に、軟膏と同様に前記水相部を緩やかに、攪拌しな
がら加温し、約80〜85℃程度になったところで、同程度
の温度に加温された油相部を徐々に添加して乳化しクリ
ームとする。
Next, similarly to the ointment, the aqueous phase was gently heated with stirring, and when the temperature reached about 80 to 85 ° C., the oil phase heated to the same temperature was gradually added. Emulsify to make a cream.

その他の皮膚外用剤においても、配合処方が水相部と
油相部を混合するものにあっては、セピアプロテインを
予め水相部に混合しておき、ついで加熱下に油相部と混
合するものであり、水相部だけから構成される皮膚外用
剤にあっては、任意の時点でセピアプロティンを配合す
ることによって、それぞれ目的とする外用剤が調製され
る。
In other skin external preparations, if the formulation is a mixture of an aqueous phase and an oil phase, sepia protein is previously mixed in the aqueous phase, and then mixed with the oil phase under heating. In the case of an external preparation for skin composed only of the aqueous phase, the desired external preparation is prepared by blending sepia protein at an arbitrary time.

セピアプロテインの効果確認 次頁に示すように、蛋白質分解酵素として、アクチナ
ーゼE、パパイン、ペプシン、トリプシンを用いて調製
したセピアプロテインの分子量を、HPLCで測定し、分解
前のイカスミ蛋白質/糖蛋白の分子量と対比して示し
た。
Confirmation of Sepia Protein Effect As shown on the next page, the molecular weight of sepia protein prepared by using actinase E, papain, pepsin, and trypsin as proteolytic enzymes was measured by HPLC. It is shown in comparison with the molecular weight.

結果 分解前のイカスミ蛋白質/糖蛋白 MW 10,000未満 40% 10,000以上30,000未満 56% 30,000以上 4% セピアプロテイン(0.005%アクチナーゼE) (pH9.0 50℃で5時間攪拌) MW 10,000未満 100% セピアプロテイン(0.05%パパイン) (pH7.0 45℃で5時間攪拌) MW 10,000未満 93% 10,000以上30,000未満 7% セピアプロテイン(0.1%ペプシン) (pH2.0 40℃で5時間攪拌) MW 10,000未満 93% 10,000以上30,000未満 7% セピアプロテイン(50units/mlトリプシン) (pH8.0 40℃で5時間攪拌) MW 10,000未満 93% 10,000以上30,000未満 7% 次に、各種セピアプロテインの白色化作用を培養細胞
によって次の方法で評価した。
Result Squid protein / glycoprotein before degradation MW less than 10,000 40% 10,000 to less than 30,000 56% 30,000 or more 4% Sepia protein (0.005% actinase E) (pH 9.0, stirred at 50 ° C for 5 hours) MW Less than 10,000 100% Sepia protein (0.05% papain) (pH 7.0, stirred at 45 ° C for 5 hours) MW less than 10,000 93% 10,000 to less than 30,000 7% sepia protein (0.1% pepsin) (pH2.0, stirred at 40 ° C for 5 hours) MW less than 10,000 93% 10,000 to less than 30,000 7% sepia protein (50 units / ml trypsin) (pH 8.0, stirring at 40 ° C for 5 hours) MW less than 10,000 93% 10,000 to less than 30,000 7% Next, the whitening effect of various sepia proteins is determined by the cultured cells. The following method evaluated.

I.B16細胞白色化作用 1) 試料の調製 試料を凍結乾燥し、培地添加試料とした。I. B16 cell whitening action 1) Preparation of sample The sample was freeze-dried and used as a medium-added sample.

2) 培地の調製 10%牛胎児血清含有Eagle's MeMを用いた。上記基本
培地に、凍結乾燥した試料を凍結乾燥前の液量に換算し
た量で、各濃度になるように添加調製した。
2) Preparation of medium Eagle's MeM containing 10% fetal calf serum was used. The freeze-dried sample was added to the above-mentioned basic medium in an amount converted to the liquid volume before freeze-drying so as to have each concentration.

コントロールには基本培地を用いた。 A basal medium was used as a control.

3) 細胞培養 細胞にはマウスメラノーマB16細胞を用いた。試験培
地を入れたプラスチックシャーレ(ファルコン3003)に
細胞を1.0×105個播種し、37℃,CO25%の条件で5日間
培養を行った。培地交換はこの間3日目に1回行った。
3) Cell culture Mouse melanoma B16 cells were used. 1.0 × 10 5 cells were seeded on a plastic petri dish (Falcon 3003) containing a test medium, and cultured at 37 ° C. for 5 days under the condition of 5% CO 2 . Medium exchange was performed once on the third day.

4) 判定方法 5日間培養液、細胞を剥離した後遠心分離し、ペレッ
トを作製して、コントロールと比較し、白色度を判定し
た。
4) Judgment method The culture solution and the cells were separated for 5 days and then centrifuged to prepare a pellet, which was compared with a control to determine the whiteness.

II.線維芽細胞増殖作用 1) 試料の調製 試料を凍結乾燥して培地添加試料とした。II. Proliferation of fibroblasts 1) Preparation of sample The sample was freeze-dried to obtain a sample added with a medium.

2) 培地の調製 基本培地には、2%牛胎児血清含有Eagle's MEMを用
いた。上記基本培地に凍結乾燥した試料を凍結乾燥前の
液量に換算した量で各濃度に成るように添加調製した。
2) Preparation of medium Eagle's MEM containing 2% fetal calf serum was used as a basic medium. A sample freeze-dried to the above-mentioned basic medium was added and adjusted to each concentration in an amount converted to a liquid amount before freeze-drying.

コントロールには基本培地を用いた。 A basal medium was used as a control.

3) 細胞培養 細胞にはマウス由来Balb/3T12−3線維芽細胞を用い
た。試験培地を入れたプラスチックシャーレ(ファルコ
ン3002)に細胞を2.0×104個播種し、5日間培養を行っ
た。培養交換はこの間1回行った。
3) Cell culture Mouse-derived Balb / 3T12-3 fibroblasts were used as cells. 2.0 × 10 4 cells were seeded on a plastic petri dish (Falcon 3002) containing a test medium, and cultured for 5 days. Culture exchange was performed once during this time.

4) 細胞の計測 5日間培養後、トリプシンで細胞を剥離し、この細胞
を自動血球計測装置(東亜医用電子(株)製)を用いて
計測した。
4) Measurement of cells After culturing for 5 days, the cells were detached with trypsin, and the cells were measured using an automatic blood cell counter (manufactured by Toa Medical Electronics Co., Ltd.).

細胞増殖作用はコントロールの細胞数に対する倍数で
表した。
The cell proliferation action was expressed as a multiple of the control cell number.

結果を次に示す。 The results are shown below.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】イカスミの蛋白質または糖蛋白質を加水分
解した液を有効成分とすることを特徴とする皮膚外用
剤。
An external preparation for skin, characterized in that a liquid obtained by hydrolyzing cuttlefish protein or glycoprotein is used as an active ingredient.
【請求項2】加水分解が、アクチナーゼ、パパイン、ペ
プシンまたはトリプシンによるものである請求項1記載
の皮膚外用剤。
2. The external preparation for skin according to claim 1, wherein the hydrolysis is caused by actinase, papain, pepsin or trypsin.
JP2052242A 1990-03-03 1990-03-03 External preparation for skin Expired - Lifetime JP2945054B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2052242A JP2945054B2 (en) 1990-03-03 1990-03-03 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2052242A JP2945054B2 (en) 1990-03-03 1990-03-03 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH03255016A JPH03255016A (en) 1991-11-13
JP2945054B2 true JP2945054B2 (en) 1999-09-06

Family

ID=12909257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2052242A Expired - Lifetime JP2945054B2 (en) 1990-03-03 1990-03-03 External preparation for skin

Country Status (1)

Country Link
JP (1) JP2945054B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210093030A (en) * 2020-01-17 2021-07-27 (주)모아캠 Composition Comprising Glycoprotein Fraction of the Flower Extract or Hydrolysate Derived from the Glycoprotein Fraction, and Method of Producing Glycoprotein Fraction of the Flower Extract and Hydrolysate Derived from the Glycoprotein Fraction

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012534A2 (en) * 1992-11-24 1994-06-09 University Of Cincinnati Melanogenic inhibitor, and methods of producing and using the same
WO2008000454A2 (en) * 2006-06-30 2008-01-03 Isdin Composition for the treatment of skin comprising ink sack liquid of cephalopods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210093030A (en) * 2020-01-17 2021-07-27 (주)모아캠 Composition Comprising Glycoprotein Fraction of the Flower Extract or Hydrolysate Derived from the Glycoprotein Fraction, and Method of Producing Glycoprotein Fraction of the Flower Extract and Hydrolysate Derived from the Glycoprotein Fraction
KR102331436B1 (en) * 2020-01-17 2021-11-29 (주)모아캠 Composition Comprising Glycoprotein Fraction of the Flower Extract or Hydrolysate Derived from the Glycoprotein Fraction, and Method of Producing Glycoprotein Fraction of the Flower Extract and Hydrolysate Derived from the Glycoprotein Fraction

Also Published As

Publication number Publication date
JPH03255016A (en) 1991-11-13

Similar Documents

Publication Publication Date Title
JPH07274977A (en) Extraction of useful plant essence, plant essence obtained by the extraction and skin-improving product containing the same essence as the active component
US20090036385A1 (en) Hair care preparation
JP3504205B2 (en) External preparation for skin
JPH10182412A (en) External-use medical preparation
KR20210066750A (en) Novel use of milk exosome
JP2008110927A (en) Cosmetic containing royal jelly protein hydrolyzate
JP2006241102A (en) Scf isolation inhibitor and external composition for skin
JP2004115438A (en) Anti-aging composition
KR20200049122A (en) Anti-aging composition comprising functional peptides and fermented products
DE4244415A1 (en) Peptide prepn contg e g, tri:peptide(s) Gly-His-Lys and/or Gly-Asp-Ser
KR20130048164A (en) Jellyfish collagen peptide mixture
JP2945054B2 (en) External preparation for skin
CN102821751A (en) Human dermal epithelial cell growth promoter, and skin composition for external use and cosmetic material including the same
JP7090886B2 (en) Hydrolyzate of watery rose apple extract and method for producing the hydrolyzate and use of the hydrolyzate
JPH10226653A (en) Promoter of collagen production, and skin preparation for external use for prevention from getting older including the same
JP3490816B2 (en) External preparation for skin
EP1066816B1 (en) Agents promoting laminin production in skin cells
JPH05262635A (en) Dermatic external preparation
JPH04282321A (en) Cosmetic
JP3507635B2 (en) Composition suitable for external use
JPH06199649A (en) Skin external preparation
JP3596953B2 (en) Whitening cosmetics
JP2834278B2 (en) Cosmetic and external preparation for skin
JP4235602B2 (en) Melanin production inhibitor and topical skin preparation
JP5171752B2 (en) Topical skin preparation

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080625

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090625

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090625

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100625

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100625

Year of fee payment: 11